Delays to anti-tuberculosis treatment intiation among cases on directly observed treatment short course in districts of southwestern Ethiopia: a cross sectional study

Table 3 Clinical characteristics and Pathways to initiate anti-TB treatment among cases on treatment Southwest Ethiopia, January to December 2015

Variable		Frequency (%)	Percent
Place TB diagnosis made	Hospital	448	61.0
	Health center	188	25.6
	Private clinic	99	13.5
Type of TB	Smear positive Pulmonary	373	50.3
	Smear negative Pulmonary	213	29.0
	Extra pulmonary	149	20.3
Mode of diagnosis	Bacteriological	373	50.7
Mode of diagnosis	Clinical	362	49.3
Weight at treatment initiation	Mean(SD)Kg	48.8
HIV status	Positive	68	9.3
HIV status	Negative	667	90.7
Receiving ART^a (n = 68)		27	39.7
Receiving CPT^b (n = 68)		32	47.1
Number of HCF visited ^c	Median (IQR)	2(1–3)
Number of visits made ^d	Median (IQR)	3(2–4)
Provider delay (days)	Median (IQR)	22(8–48)
Provider delay (days)	Median(95%CI)	22(19,25)
Total delay (days)	Median (IQR)	55(32–100)
Total delay (days)	Median (95%CI)	55(49,61)

^aAntiretroviral therapy ^b Cotrimoxazole Prohylactic therapy ^c number of HCF visited until diagnosis of TB is made, ^d number of total visits made to different HCF until TB diagnosis

ISSN: 1471-2334